Aflac
AFL
$116.02
+0.15%
Aflac Inc. is a leading provider of supplemental health and life insurance, operating primarily in the United States and Japan, with a strong focus on cancer, accident, dental, vision, disability, and long-term-care policies. The company differentiates itself through its dominant market position in the Japanese supplemental insurance market and its unique worksite distribution model, which allows it to reach customers directly at their places of employment. Currently, the investor narrative centers on Aflac's strategic use of AI-driven efficiency to enhance operational performance and its robust capital return program, which combines dividends and share buybacks to deliver attractive shareholder yields. The company is also navigating the complexities of its Japan segment, which generates the majority of revenue, amid currency fluctuations and evolving market conditions.…
AFL
Aflac
$116.02
Related headlines
AFL 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aflac's 12-month outlook, with a consensus price target around $118.53 and implied upside of +2.2% versus the current price.
Average Target
$118.53
0 analysts
Implied Upside
+2.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$99 - $138
Analyst target range
The target price range spans from a low of $99.00 to a high of $138.00, representing a wide spread of approximately 39% from low to high. The high target of $138.00 assumes that Aflac can achieve stronger-than-expected growth, potentially driven by AI-driven efficiency gains and successful expansion in the U.S. market, while the low target of $99.00 prices in risks such as margin compression, competitive pressures, or adverse currency movements in Japan. The wide spread suggests significant uncertainty among analysts about Aflac's future performance, which is typical for a company with a large international exposure and evolving business model. Recent institutional ratings have been largely neutral, with no major upgrades or downgrades, indicating that analysts are waiting for more clarity on the company's strategic initiatives and their impact on financial results.
Bulls vs Bears: AFL Investment Factors
Aflac presents a mixed picture: strong revenue growth, solid margins, and a robust capital return program are countered by recent price weakness, underperformance vs. the market, and heavy reliance on Japan. The bull case is supported by accelerating growth and defensive characteristics, while the bear case hinges on limited analyst upside and potential currency headwinds. Currently, the evidence slightly favors the bull case given the strong fundamental momentum and reasonable valuation, but the key tension is whether the recent revenue acceleration is sustainable and can translate into consistent earnings growth. If growth continues, the stock could re-rate higher; if it falters, the stock may remain range-bound.
Bullish
- Revenue growth accelerating sharply: Q1 2026 revenue surged 24.96% YoY to $4.315B, a major acceleration from prior quarters. This growth is driven by strong performance in both Japan and U.S. segments, indicating successful expansion and market penetration.
- Strong profitability and margins: Q1 2026 net margin was 23.6%, with operating margin at 28.4%, reflecting efficient cost management. The trailing PE of 16.07x is reasonable for an insurer, and the forward PE of 15.45x suggests modest earnings growth expectations.
- Robust capital return program: Aflac offers a dividend yield of 2.05% and a payout ratio of 32.9%, complemented by share buybacks. Recent news highlights an effective 8.3% total yield when including buybacks, making it attractive for income investors.
- Low beta and defensive characteristics: With a beta of 0.595, Aflac is significantly less volatile than the market, providing portfolio stability. This is particularly valuable in uncertain economic conditions, as the stock tends to hold up better during downturns.
Bearish
- Recent price momentum has stalled: The stock is down 9.44% over the past month and has pulled back from its 52-week high of $130.22, currently trading at $116.52. This suggests waning investor enthusiasm and potential near-term headwinds.
- Underperformance relative to market: Over the past year, Aflac gained 9.82% while the S&P 500 rose 18.56%, underperforming by 8.74 percentage points. This relative weakness may persist if investors favor higher-growth sectors.
- Dependence on Japan segment: Aflac Japan generates the majority of revenue, exposing the company to currency fluctuations and demographic challenges. The yen's volatility can significantly impact earnings, as seen in historical earnings swings.
- Analyst consensus is neutral: With a recommendation of 'hold' and an average target price of $118.53, analysts see limited upside of only 1.7% from the current price. The wide target range ($99-$138) reflects uncertainty about future performance.
AFL Technical Analysis
Aflac's stock is in a clear uptrend over the past year, with a 1-year price change of +9.82%, though it has recently pulled back from its highs. The current price of $116.52 sits at approximately 89.5% of its 52-week range (between $104.66 and $130.22), indicating that while the stock remains relatively close to its highs, it has retreated from the peak. This positioning suggests that the stock is still in a bullish phase but may be experiencing a corrective pullback after a strong run, offering a potential entry point for investors looking for momentum with a margin of safety.
Beta
0.59
0.59x market volatility
Max Drawdown
-10.6%
Largest decline past year
52-Week Range
$105-$130
Price range past year
Annual Return
+8.6%
Cumulative gain past year
| Period | AFL Return | S&P 500 |
|---|---|---|
| 1m | -9.0% | +2.0% |
| 3m | +1.3% | +1.0% |
| 6m | +4.5% | +11.8% |
| 1y | +8.6% | +18.1% |
| ytd | +5.2% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AFL Fundamental Analysis
Aflac's revenue trajectory has been robust, with the most recent quarter (Q1 2026) reporting revenue of $4.315 billion, a 24.96% year-over-year increase. This growth is a significant acceleration from prior quarters, as Q1 2025 revenue was only $3.453 billion, and the company has consistently grown revenue from $3.035 billion in Q3 2024 to $4.896 billion in Q4 2025. The growth is driven by strong performance in both the Japan and U.S. segments, with Aflac Japan contributing $2.172 billion and Aflac U.S. contributing $1.779 billion in the latest quarter. This accelerating growth trajectory indicates that Aflac is successfully expanding its product offerings and market reach, which is a positive signal for the investment case.
Quarterly Revenue
$4.3B
2026-03
Revenue YoY Growth
+25.0%
YoY Comparison
Gross Margin
57.5%
Latest Quarter
Free Cash Flow
$2.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AFL Overvalued?
Given that Aflac has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 16.07x, while the forward PE is 15.45x, indicating that the market expects earnings to grow slightly in the coming year. The gap between trailing and forward PE is narrow, suggesting that the market's growth expectations are modest but positive. This is consistent with Aflac's stable but not explosive earnings growth profile, as evidenced by its EPS of $1.99 in Q1 2026, which is a significant improvement from the $0.05 EPS in Q1 2025, but still subject to quarterly volatility.
PE
16.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Aflac's earnings are subject to significant volatility due to investment gains and losses, as evidenced by EPS swinging from $0.05 in Q1 2025 to $3.09 in Q3 2025. The company's net margin of 20.9% is respectable, but the reliance on investment income can lead to unpredictable results. Additionally, the Japan segment's contribution is sensitive to currency movements; a stronger yen could boost earnings, but a weaker yen could compress margins. The debt-to-equity ratio of 0.285 is low, but the company's high current ratio of 12.39 suggests excess liquidity that could be deployed more efficiently. Overall, the financial risk is moderate, with the main concern being earnings predictability.